There was a slight trend of increasing plasma C max with decreasing age but was not exhibited of plasma AUC 0–t ( Figure 3 ).
← all excerpts
Clinical Pharmacokinetics and Pharmacodynamics of Cerliponase Alfa, Enzyme Replacement Therapy for CLN2 Disease by Intracerebroventricular Administration.
1
—
—